200 related articles for article (PubMed ID: 23604100)
21. Case Report: A Case of Type 1 Leprosy Reaction and Dapsone Hypersensitivity Syndrome Complicating the Clinical Course of Multibacillary Leprosy.
Craig J; MacRae C; Melvin RG; Boggild AK
Am J Trop Med Hyg; 2019 May; 100(5):1145-1148. PubMed ID: 30915953
[TBL] [Abstract][Full Text] [Related]
22. Sparing of tuberculoid leprosy patch in a patient with dapsone hypersensitivity syndrome.
Ng PP; Goh CL
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):646-8. PubMed ID: 9777777
[No Abstract] [Full Text] [Related]
23. Dapsone-induced agranulocytosis in a patient of leprosy.
Mishra M; Chhetia R
Indian J Dermatol Venereol Leprol; 2006; 72(6):456-7. PubMed ID: 17179627
[No Abstract] [Full Text] [Related]
24. A lethal case of the dapsone hypersensitivity syndrome involving the myocardium.
Hoogeveen RM; van der Bom T; de Boer HH; Thurlings RM; Wind BS; de Vries HJ; van Lent AU; Beuers U; van der Wal AC; Nellen FJ
Neth J Med; 2016 Feb; 74(2):89-92. PubMed ID: 26951355
[TBL] [Abstract][Full Text] [Related]
25. Acute Generalized Exanthematous Pustulosis (AGEP) due to dapsone in a patient with leprosy.
Narasimharao P; Pratap DV; Suneetha S
Lepr Rev; 2009 Mar; 80(1):81-4. PubMed ID: 19472855
[No Abstract] [Full Text] [Related]
26. Renal hypersensitivity vasculitis associated with dapsone.
Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Rabel-Filho OC; Martini-Filho D; Fontes CJ
Am J Kidney Dis; 2005 Oct; 46(4):e51-3. PubMed ID: 16183407
[TBL] [Abstract][Full Text] [Related]
27. Urinary tract carcinoma in leprosy patients treated with dapsone for a long period.
Hironaka K; Mizushima M; Tsuzi C; Makino H
Nephron; 1997; 76(3):358-9. PubMed ID: 9226243
[No Abstract] [Full Text] [Related]
28. Dapsone hypersensitivity syndrome with coexisting acute hepatitis E.
Chogle A; Nagral A; Soni A; Agale S; Jamadar Z
Indian J Gastroenterol; 2000; 19(2):85-6. PubMed ID: 10812824
[TBL] [Abstract][Full Text] [Related]
29. Dapsone syndrome: an incomplete form.
Jaswal R; Thami GP; Kanwar AJ
Indian J Lepr; 1998; 70(2):229-30. PubMed ID: 9724867
[No Abstract] [Full Text] [Related]
30. Dapsone-induced eosinophilic pneumonitis in a leprosy patient.
Kaur J; Khandpur S; Seith A; Khanna N
Indian J Lepr; 2005; 77(3):267-71. PubMed ID: 16353525
[TBL] [Abstract][Full Text] [Related]
31. Dapsone hypersensitivity syndrome in a lepromatous leprosy patient--A Case Report.
Gavilanes MC; Palacio AL; Chellini PR; Nery JA; Rego JG
Lepr Rev; 2015 Jun; 86(2):186-90. PubMed ID: 26502691
[TBL] [Abstract][Full Text] [Related]
32. Side-effects of antileprosy drugs in common use.
Jopling WH
Lepr Rev; 1983 Dec; 54(4):261-70. PubMed ID: 6199637
[No Abstract] [Full Text] [Related]
33. Dapsone hypersensitivity syndrome in an adolescent during treatment during of leprosy.
Bucaretchi F; Vicente DC; Pereira RM; Tresoldi AT
Rev Inst Med Trop Sao Paulo; 2004; 46(6):331-4. PubMed ID: 15654479
[TBL] [Abstract][Full Text] [Related]
34. Dapsone: An Update.
Karjigi S; Murthy SC; Kallappa H; Kusuma MR; Aruna B; Reddy YN
Indian J Lepr; 2016 Sep; 87(4):233-239. PubMed ID: 29762952
[TBL] [Abstract][Full Text] [Related]
35. Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan.
Sheen YS; Chu CY; Wang SH; Tsai TF
J Dermatolog Treat; 2009; 20(6):340-3. PubMed ID: 19954390
[TBL] [Abstract][Full Text] [Related]
36. Side-effects of Isoprodian compared with WHO-MDT in rural Nepal.
van Brakel WH; Drever W
Lepr Rev; 1993 Sep; 64(3):276-80. PubMed ID: 8231610
[No Abstract] [Full Text] [Related]
37. Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity.
Ranawaka RR; Mendis S; Weerakoon HS
Lepr Rev; 2008 Dec; 79(4):436-40. PubMed ID: 19274991
[TBL] [Abstract][Full Text] [Related]
38. A double blow for a patient with leprosy: a reversal reaction and an adverse drug reaction.
Thangaraju P; Venkatesan S
Lancet; 2019 Oct; 394(10207):1450. PubMed ID: 31631856
[No Abstract] [Full Text] [Related]
39. Dapsone-induced acute myopia.
Gopalani VV; More AS
Indian J Dermatol Venereol Leprol; 2006; 72(6):455-6. PubMed ID: 17179626
[No Abstract] [Full Text] [Related]
40. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
Sapkota BR; Shrestha K; Pandey B; Walker SL
Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
